Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cibinetide for Sale > high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - large image1
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - image1
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - image2
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - image3
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - image4
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - image5
high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide buy - image6

high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide

24 Inquiries

Unit Price:

$100-130/G FOB

Get Latest Price
CAS No.:

1208243-50-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

qingdao

Brand:

sinov

Packaging:

vial/box

Price valid (until):

2026-10-09

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Description

    ARA-290 (International Nonproprietary Name: Cibinetide, also known as pHBSP) is a synthetic 11-amino-acid polypeptide with CAS number 1208243-50-8, molecular formula C₅₁H₈₄N₁₆O₂₁ and molecular weight 1257.3. It is modified from the helix B domain of the erythropoietin (EPO) molecule. While retaining the tissue-protective properties, it loses the erythropoiesis-stimulating activity, making it a representative peptide tool compound in the research of tissue repair and anti-inflammation. This product is supplied as high-purity lyophilized powder (≥98%, determined by HPLC), featuring stable properties for easy storage and experimental preparation.

    Key Effects

    The most core feature of ARA-290 lies in its mechanism of action of "selective activation". It can specifically bind to the innate repair receptor (IRR), a heterodimer composed of the EPO receptor and the β-common receptor CD131. This receptor is normally transiently expressed in damaged tissues and participates in initiating tissue repair and protective processes. Meanwhile, ARA-290 does not act on the classical EPO receptor responsible for erythropoiesis, so it does not cause changes in red blood cell count. This design endows it with unique research value in tissue protection studies.

    Specifically, its effects demonstrated in scientific research experiments include:
    Selective receptor activation: It specifically activates the innate repair receptor (IRR) to initiate signal pathways related to tissue protection without stimulating erythropoiesis.
    Tissue protection and repair: It has been observed to possess research potential for tissue protection and repair promotion in multiple animal models.
    Inflammatory regulatory effect: Research data indicates that it is associated with the regulation of various inflammatory factors, serving as a commonly used tool molecule for anti-inflammatory mechanism research.
    Research value in neuroprotection: Relevant manifestations of neuroprotection and nerve fiber repair have been observed in research models related to neuropathy.
    Clear mechanism of action: It has a well-defined target and short structure, facilitating molecular-level mechanistic research such as receptor binding and signal pathway investigation.

    Applications

    ARA-290 is currently mainly applied in scientific research related to tissue protection, neuroscience and inflammation, covering various experimental scenarios ranging from molecular mechanisms to animal models. It serves as a representative tool compound in the research of EPO-derived polypeptides and also provides an important reference molecule for the research and development of a new generation of tissue-protective polypeptide drugs.

    Specific research application scenarios include:
    Tissue protection and repair research: Used to study protective mechanisms and repair pathways in models of tissue injury, ischemia-reperfusion, etc.
    Neuropathy research: Suitable for animal model and mechanism research in fields such as diabetic neuropathy and neuropathic pain.
    Inflammatory mechanism research: Applied in inflammation-related experiments including inflammatory factor regulation and immune cell polarization.
    Metabolic disease research: Used as a tool compound in studies on metabolic control and complications associated with type 2 diabetes.
    Drug research and development reference: As a representative molecule of non-erythropoietic EPO-derived peptides, it is utilized for polypeptide structure optimization and lead compound research.
    In vitro cellular and molecular experiments: Can be used for molecular-level experiments such as evaluation of receptor binding activity and study of downstream signaling pathways.

    Shop high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide-Detailed Image 1 Shop high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide-Detailed Image 2 Shop high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide-Detailed Image 3 Shop high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide-Detailed Image 4 Shop high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide-Detailed Image 5


    Items Specifications
    ARA-290 10mg
    ARA-290 1g
    ARA-290 1kg
    ECHEMI Editorial Reference
    Cibinetide, also known as ARA-290, is a synthetic 11-mer peptide that binds the tissue-protective receptor. ARA290 inhibits high glucose-induced apoptosis of NRK-52E cells. Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation. Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.
    Research & Reference Note

    high purity ARA-290(Cibinetide) acetate/Neuroprotective, Anti-Inflammatory/EPO derived peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Basic Info
    Product Name:

    Cibinetide

    Other Name:

    ARA-290 (Cibinetide);ARA290, >98%;ARA290,Cibinetide, >98%;ARA290;WZTIQQBMSJTRBR-MUZUOSMHSA-N;ara290/Poziotinib;L-Serine, 5-oxo-L-prolyl-L-α-glutamyl-L-glutaminyl-L-leucyl-L-α-glutamyl-L-arginyl-L-alanyl-L-leucyl-L-asparaginyl-L-seryl-;ARA-290(Cibinetide) acetate

    CAS No.:

    1208243-50-8

    Molecular Formula:

    C51H84N16O21

    InChIKeys:

    WZTIQQBMSJTRBR-WYKNNRPVSA-N

    Molecular Weight:

    1257.31

    EC Number:

    200-001-8

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.56±0.1 g/cm3(Predicted)

    PKA:

    2.90±0.10(Predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Factory Supply 99% Purity Ara 290 Peptides Raw Lyophilized Powder CAS 1208243-50-8

    1 G Oct 29, 2023
    United States

    ARA-290

    15 MG Aug 3, 2026
    United States

    ARA 290

    1 G Apr 13, 2026
    United States

    ARA-290 Peptide

    1 G Feb 6, 2026
    United States

    ARA-290

    10 PCS Nov 15, 2025
    Thailand

    Cibinetide

    200 KG May 10, 2025
    Lithuania

    ARA 290

    60  Nov 28, 2023
    United States

    Ara 290

    100 MG Aug 4, 2026
    United States

    ARA-290 10mg

    100 PCS Apr 17, 2026
    United States

    ARA-290

    10 MT May 10, 2024
    Denmark

    Cibinetide

    5 G Feb 11, 2024
    Lithuania

    ARA 290

    10  Nov 28, 2023
    Philippines

    I am looking for Ara 290 100 vials

    30 MT Aug 5, 2026
    United States

    Ara-290

    20 MG Jul 20, 2026
    United States

    ARA 290

    1 KG Jun 15, 2026
    Belgium

    ARA290

    1 KG May 20, 2026
    United States

    Reta

    60  May 4, 2026
    United States

    ARA-290 Lyophilized

    800 MG Apr 17, 2026
    United States

    Ara290

    1 G Apr 17, 2026
    Nigeria

    Snap 8

    100 PCS Apr 10, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.